Shifteh Sattar
Neurology with Special Qualifications in Child Neurology · San Diego, CANPI 1750407300
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.2%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by UCB, Inc. at 40.8% of the total. 2025 is the largest year on record at $9,742, 5.5 times the $1,755 reported in 2019.
Across 301 payments — averaging $68.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$8K
- Aucta Pharmaceuticals, Inc.$3K
- Medtronic$2K
- Neuropace, Inc.$2K
- Jazz Pharmaceuticals Inc.$2K
- Neurelis, Inc.$838
- plus $3K from 23 others
Across 14 payments — averaging $20,084 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Immedica Pharma US, Inc.$281K
What the payments were for
- Consulting fees$5,10025%
- Speaking & faculty fees$3,10015%
- Travel & lodging$2,30311%
- Food & beverage$10,18149%
- Education$90%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 40 | $8,447 |
| Aucta Pharmaceuticals, Inc. | 4 | $2,559 |
| Medtronic | 21 | $2,091 |
| Neuropace, Inc. | 39 | $1,755 |
| Jazz Pharmaceuticals Inc. | 23 | $1,556 |
| Neurelis, Inc. | 32 | $838 |
| Sunovion Pharmaceuticals Inc. | 49 | $744 |
| Greenwich Biosciences, Inc. | 11 | $642 |
| Livanova USA, Inc. | 22 | $350 |
| SK Life Science, Inc. | 4 | $331 |
| Eisai Inc. | 8 | $164 |
| Catalyst Pharmaceuticals, Inc. | 6 | $156 |
| Acadia Pharmaceuticals Inc | 6 | $153 |
| Immedica Pharma US, Inc. | 4 | $143 |
| Mallinckrodt Enterprises LLC | 1 | $118 |
| Aquestive Therapeutics, Inc. | 4 | $100 |
| Upsher-smith Laboratories LLC | 4 | $96 |
| Zimmer Biomet | 1 | $65 |
| CSL Behring | 4 | $63 |
| Biocodex, Inc. | 3 | $62 |
| Pyros Pharmaceuticals, Inc. | 2 | $54 |
| Novartis | 3 | $49 |
| Sumitomo Pharma America, Inc. | 2 | $39 |
| Azurity Pharmaceuticals, Inc. | 2 | $35 |
| NS Pharma, Inc. | 1 | $23 |
| Zogenix Inc. | 1 | $22 |
| Vertical Pharmaceuticals, LLC | 1 | $15 |
| Biomarin Pharmaceutical Inc. | 1 | $15 |
| Travere Therapeutics, Inc. | 2 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Fintepla$7,388
- Motpoly XR$2,500
- VISUALASE$1,272
- Epidiolex$1,258
- VALTOCO$135
- ACTHAR$118
- RNS System$114
- RNS Neurostimulator Kit$102
How this compares
$20,693 in reported general payments places this provider in the 85th percentile of 216 neurology with special qualifications in child neurology providers in California.
See all neurology with special qualifications in child neurology providers in California →
Other neurology with special qualifications in child neurology in San Diego
- Brittany PassiakSan Diego$90K
- Joseph GleesonSan Diego$69K
- John CrawfordSan Diego$27K
- Richard HaasSan Diego$27K
- Jennifer YangSan Diego$15K
- Doris TraunerSan Diego$15K
- Olivia Kim McManusSan Diego$11K
- Katherine LongardnerSan Diego$11K
- Aliya FrederickSan Diego$7K
- Michael ChezSacramento$374K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.